zalifrelimab
-
October 8, 2020
Preliminary Results of Two Large Immune Therapy Studies Show Promise in Advanced Cervical Cancer Bookmark
George Lundberg, MDPress release from Ohio State University Wexner Medical Center curated by Contributing Editor George Lundberg, MD.
This press release outlines promising preliminary results from two phase 2 clinical trials testing the drug balstilimab alone or in combination with zalifrelimab.
.